| | |
| Clinical data | |
|---|---|
| Drug class | NAMPT positive allosteric modulator |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C26H38N2O3 |
| Molar mass | 426.601 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
JGB-1-155, is a drug which acts as a selective positive allosteric modulator of the enzyme nicotinamide phosphoribosyltransferase (NAMPT). It has neuroprotective effects, and was developed as a potential treatment for neurodegenerative diseases such as Alzheimer's disease. [1]